Related Content
Search Google Scholar for:
|
|
Science 28 March 1986: Vol. 231. no. 4745, pp. 1549 - 1553 DOI: 10.1126/science.3006244
|
|
Articles
Science, Vol 231, Issue 4745, 1549-1553
Copyright © 1986 by American Association for the Advancement of Science
Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions
J Sodroski,
WC Goh,
C Rosen,
A Tartar,
D Portetelle,
A Burny,
and
W Haseltine
The genome of the human T-lymphotropic virus type III (HTLV-III/LAV) has the potential to encode at least three polypeptides in addition to those encoded by the gag, pol, and env genes. In this study, the product of the sor (short open reading frame) region, which overlaps the 3' end of the pol gene, was found to be a protein with a molecular weight of 23,000. An assay was developed for testing the ability of cloned HTLV-III proviruses to produce viruses cytopathic for T4+ lymphocytes. In the cell line used, C8166, neither the HTLV-III sor gene product nor the complete 3'-orf gene product were necessary for the replication or cytopathic effects of the HTLV-III.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state.
- T. H. Reingewertz, H. Benyamini, M. Lebendiker, D. E. Shalev, and A. Friedler (2009)
Protein Eng. Des. Sel.
22, 281-287
| Abstract »
| Full Text »
| PDF »
- Inhibition of Formula-Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency Virus Type 1 Replication.
- F. Guo, S. Cen, M. Niu, J. Saadatmand, and L. Kleiman (2006)
J. Virol.
80, 11710-11722
| Abstract »
| Full Text »
| PDF »
- Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging.
- K. Luo, B. Liu, Z. Xiao, Y. Yu, X. Yu, R. Gorelick, and X.-F. Yu (2004)
J. Virol.
78, 11841-11852
| Abstract »
| Full Text »
| PDF »
- The Interaction between HIV-1 Gag and APOBEC3G.
- S. Cen, F. Guo, M. Niu, J. Saadatmand, J. Deflassieux, and L. Kleiman (2004)
J. Biol. Chem.
279, 33177-33184
| Abstract »
| Full Text »
| PDF »
- Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication.
- Y.-H. Zheng, D. Irwin, T. Kurosu, K. Tokunaga, T. Sata, and B. M. Peterlin (2004)
J. Virol.
78, 6073-6076
| Abstract »
| Full Text »
| PDF »
- Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G.
- B. Liu, X. Yu, K. Luo, Y. Yu, and X.-F. Yu (2004)
J. Virol.
78, 2072-2081
| Abstract »
| Full Text »
| PDF »
- Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex.
- X. Yu, Y. Yu, B. Liu, K. Luo, W. Kong, P. Mao, and X.-F. Yu (2003)
Science
302, 1056-1060
| Abstract »
| Full Text »
| PDF »
- Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Replication by a Two-Amino-Acid Insertion in HIV-1 Vif from a Nonprogressing Mother and Child.
- L. Alexander, M. J. Aquino-DeJesus, M. Chan, and W. A. Andiman (2002)
J. Virol.
76, 10533-10539
| Abstract »
| Full Text »
| PDF »
- Functional Neutralization of HIV-1 Vif Protein by Intracellular Immunization Inhibits Reverse Transcription and Viral Replication.
- J. Goncalves, F. Silva, A. Freitas-Vieira, M. Santa-Marta, R. Malho, X. Yang, D. Gabuzda, and C. Barbas III (2002)
J. Biol. Chem.
277, 32036-32045
| Abstract »
| Full Text »
| PDF »
- Vif Is Largely Absent from Human Immunodeficiency Virus Type 1 Mature Virions and Associates Mainly with Viral Particles Containing Unprocessed Gag.
- P. Sova, D. J. Volsky, L. Wang, and W. Chao (2001)
J. Virol.
75, 5504-5517
| Abstract »
| Full Text »
| PDF »
- Role of Vif in Stability of the Human Immunodeficiency Virus Type 1 Core.
- A. Ohagen and D. Gabuzda (2000)
J. Virol.
74, 11055-11066
| Abstract »
| Full Text »
| PDF »
- Association of Human Immunodeficiency Virus Type 1 Vif with RNA and Its Role in Reverse Transcription.
- M. Dettenhofer, S. Cen, B. A. Carlson, L. Kleiman, and X.-F. Yu (2000)
J. Virol.
74, 8938-8945
| Abstract »
| Full Text »
| PDF »
- Tumor Necrosis Factor (TNF)-{alpha} and TNF Receptors in Viral Pathogenesis.
- G. Herbein and W. A. O'brien (2000)
Experimental Biology and Medicine
223, 241-257
| Abstract »
| Full Text »
- Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of Vif for optimal infectivity: functional difference between Vif and Nef.
- H. Akari, T. Uchiyama, T. Fukumori, S. Iida, A. H. Koyama, and A. Adachi (1999)
J. Gen. Virol.
80, 2945-2949
| Abstract »
| Full Text »
- Highly Purified Human Immunodeficiency Virus Type 1 Reveals a Virtual Absence of Vif in Virions.
- M. Dettenhofer and X.-F. Yu (1999)
J. Virol.
73, 1460-1467
| Abstract »
| Full Text »
| PDF »
- Conservation of an Intact vif Gene of Human Immunodeficiency Virus Type 1 during Maternal-Fetal Transmission.
- V. R. K. Yedavalli, C. Chappey, E. Matala, and N. Ahmad (1998)
J. Virol.
72, 1092-1102
| Abstract »
| Full Text »
| PDF »
- A novel gene of HIV-1, vpu, and its 16-kilodalton product.
- K Strebel, T Klimkait, and M. Martin (1988)
Science
241, 1221-1223
| Abstract »
| PDF »
- Human immunodeficiency virus may encode a novel protein on the genomic DNA plus strand.
- R. Miller (1988)
Science
239, 1420-1422
| Abstract »
| PDF »
- Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.
- T. Folks, J Justement, A Kinter, C. Dinarello, and A. Fauci (1987)
Science
238, 800-802
| Abstract »
| PDF »
- The sor gene of HIV-1 is required for efficient virus transmission in vitro.
- A. Fisher, B Ensoli, L Ivanoff, M Chamberlain, S Petteway, L Ratner, R. Gallo, and F Wong-Staal (1987)
Science
237, 888-893
| Abstract »
| PDF »
|
|